Mitochondrial quality control in ischemic stroke: mitophagy, ferroptosis and emerging evidence for cuproptosis

Stroke is a leading cause of death and disability worldwide, and ischemic stroke is its most common subtype. Cerebral ischemia-reperfusion injury (CIRI) involves oxidative stress, inflammation and blood-brain barrier disruption, making mitochondrial quality control and regulated cell death important targets for mechanistic research. This review examines mitophagy, ferroptosis and emerging evidence for cuproptosis within a mitochondrial framework, while distinguishing established mechanisms from model-dependent findings and untested hypotheses. Ferroptosis is supported by substantial experimental evidence in stroke. Thrombin–ACSL4 signaling and NCOA4-mediated ferritinophagy can promote lipid peroxidation and iron dysregulation, respectively, whereas the system Xc – /GSH/GPX4 axis counteracts ferroptosis by supporting lipid-hydroperoxide detoxification. FSP1–CoQ10, DHODH–CoQ10 and GCH1–BH4 provide additional antioxidant mechanisms, although their stroke-specific contributions remain incompletely defined. Mitophagy operates through PINK1/Parkin, BNIP3/NIX and FUNDC1 pathways and can have protective or detrimental effects depending on pathway activity, lysosomal function and mitochondrial reserve. Experimental studies support selected connections between mitochondrial quality control and ferroptosis, but proposed competition between mitophagy and ferritinophagy remains unverified. Itaconate-mediated GPX4 alkylation and IRG1-associated mitophagy represent distinct mechanisms reported in different hemorrhagic stroke models. In contrast, copper-homeostasis changes and FDX1 perturbation in ischemic models do not establish the complete cuproptosis mechanism. We therefore distinguish copper/FDX1 intervention evidence, bioinformatic associations and contextual mechanistic clues. A possible mitophagy–cuproptosis tolerance relationship is presented as a testable hypothesis whose selective recognition signals, receptors and quantitative requirements remain unresolved. Therapeutic timing is discussed conceptually without fixed intervention windows. Future progress requires mechanism-specific assays, time-resolved mitophagic flux measurements, genetic rescue and validation across relevant brain cell types and clinically representative models.

Authors

Institutions

Publication Details

Journal
Frontiers in Cellular Neuroscience
Published
2026-11-16
DOI
https://doi.org/10.3389/fncel.2026.1990312
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mitochondrial quality control in ischemic stroke: mitophagy, ferroptosis and emerging evidence for cuproptosis

Jianpeng Guo, Bin Shi, Xitao Li
2 links
Frontiers in Cellular Neuroscience
Autophagy in Disease and Therapy
article

Mitochondrial quality control in ischemic stroke: mitophagy, ferroptosis and emerging evidence for cuproptosis

Jianpeng Guo, Bin Shi, Xitao Li
article en

Abstract

Stroke is a leading cause of death and disability worldwide, and ischemic stroke is its most common subtype. Cerebral ischemia-reperfusion injury (CIRI) involves oxidative stress, inflammation and blood-brain barrier disruption, making mitochondrial quality control and regulated cell death important targets for mechanistic research. This review examines mitophagy, ferroptosis and emerging evidence for cuproptosis within a mitochondrial framework, while distinguishing established mechanisms from model-dependent findings and untested hypotheses. Ferroptosis is supported by substantial experimental evidence in stroke. Thrombin–ACSL4 signaling and NCOA4-mediated ferritinophagy can promote lipid peroxidation and iron dysregulation, respectively, whereas the system Xc – /GSH/GPX4 axis counteracts ferroptosis by supporting lipid-hydroperoxide detoxification. FSP1–CoQ10, DHODH–CoQ10 and GCH1–BH4 provide additional antioxidant mechanisms, although their stroke-specific contributions remain incompletely defined. Mitophagy operates through PINK1/Parkin, BNIP3/NIX and FUNDC1 pathways and can have protective or detrimental effects depending on pathway activity, lysosomal function and mitochondrial reserve. Experimental studies support selected connections between mitochondrial quality control and ferroptosis, but proposed competition between mitophagy and ferritinophagy remains unverified. Itaconate-mediated GPX4 alkylation and IRG1-associated mitophagy represent distinct mechanisms reported in different hemorrhagic stroke models. In contrast, copper-homeostasis changes and FDX1 perturbation in ischemic models do not establish the complete cuproptosis mechanism. We therefore distinguish copper/FDX1 intervention evidence, bioinformatic associations and contextual mechanistic clues. A possible mitophagy–cuproptosis tolerance relationship is presented as a testable hypothesis whose selective recognition signals, receptors and quantitative requirements remain unresolved. Therapeutic timing is discussed conceptually without fixed intervention windows. Future progress requires mechanism-specific assays, time-resolved mitophagic flux measurements, genetic rescue and validation across relevant brain cell types and clinically representative models.

Frontiers in Cellular NeuroscienceVol. 20
Gansu Provincial Hospital (CN), Gansu Provincial Hospital of TCM (CN)
Good health and well-being
Autophagy in Disease and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon